FDA accepts Takeda's application for pediatric ENTYVIO treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. IBM
5. SPY
6. ACN
7. NVDA
8. PRIM
9. META
10. PFE

Go back to FDA accepts Takeda's application for pediatric ENTYVIO treatment
(NYSE: TAK) Delayed: 15.80 +0.33 (2.13%)
Previous Close $15.47    52 Week High $0.55 
Open $15.65    52 Week Low $0.55 
Day High $15.80    P/E N/A 
Day Low $15.50    EPS $-0.20 
Volume 1,096,556